Inflammation in neurological and psychiatric diseases (Q37987805)

26 August 2017

title

Inflammation in neurological and psychiatric diseases (English)

1 reference

26 August 2017

0 references

Parto S Khansari

1

1 reference

26 August 2017

Beata Sperlagh

series ordinal

2

1 reference

26 August 2017

language of work or name

1 reference

24 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

20

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

103-107

1 reference

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Neuronal damage in brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Inflammation in central nervous system injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Serologic evidence of prenatal influenza in the etiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Maternal infections and subsequent psychosis among offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Inflammation and gliosis in neurological diseases--clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Twenty years of research on cytokine-induced sickness behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Depression is a risk factor for mortality after myocardial infarction: fact or artifact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Inflammatory markers in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Activated astroglia during chronic inflammation in Alzheimer's disease--do they neglect their neurosupportive roles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Childhood meningitis, brain maturation and the risk of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Theories of schizophrenia: a genetic-inflammatory-vascular synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

The immunology of stroke: from mechanisms to translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Psychosocial predictors of health-related quality of life and health service utilisation in people with chronic low back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

21 January 2018

Physiology of microglia

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Inflammation in the early stages of neurodegenerative pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Clinical effects of COX-2 inhibitors on cognition in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Paroxetine for the prevention of depression induced by high-dose interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

TNFalpha-induced sickness behavior in mice with functional 55 kD TNF receptors is blocked by central IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Microglia in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Microglial physiology: unique stimuli, specialized responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

The hygiene hypothesis and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Cytokines and depression: findings, issues, and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

The brain as a target for inflammatory processes and neuroprotective strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Reactive astrocytes in neural repair and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

A final common pathway for depression? Progress toward a general conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Microglia and neuroinflammation: a pathological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

The inflammatory response in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Inflammation in Neurological Disorders: A Help or a Hindrance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Blood-brain barrier breakdown in acute and chronic cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Targeting astrocytes for stroke therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-012-0124-X

Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression

21 January 2018

1 reference

12 December 2020

Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology

1 reference

12 December 2020

Inflammatory mechanisms in major depressive disorder

1 reference

12 December 2020

Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia.

1 reference

12 December 2020

The role of inflammation in CNS injury and disease

1 reference

12 December 2020

Inflammasome signaling at the heart of central nervous system pathology

1 reference

12 December 2020

COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence

1 reference

12 December 2020

Where there is depression, there is inflammation... sometimes!

1 reference

12 December 2020

Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease.

1 reference

12 December 2020

Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression

1 reference

12 December 2020

A meta-analysis of cytokines in major depression

1 reference

12 December 2020

Inflammatory mechanisms in ischemic stroke: role of inflammatory cells

1 reference

12 December 2020

Cytokines in Parkinson's disease

1 reference

12 December 2020

Fibrin degradation products in post mortem brain tissue of schizophrenics: a possible marker for underlying inflammatory processes

1 reference

12 December 2020

The astrocyte odyssey

1 reference

12 December 2020

The role of astrocytes in the physiology and pathology of the central nervous system

1 reference

12 December 2020

Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence.

1 reference

12 December 2020

10.1007/S10787-012-0124-X

Identifiers

DOI

1 reference

26 August 2017

1 reference